Six stabs in the back of proton pump inhibitors

Proton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumati...

Full description

Bibliographic Details
Main Author: Andrei Evgenyevich Karateev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2013-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1658
id doaj-82c5609b1c274ca2aae4a0df87abf604
record_format Article
spelling doaj-82c5609b1c274ca2aae4a0df87abf6042021-08-02T09:05:44ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922013-06-0151333234010.14412/1995-4484-2013-15091595Six stabs in the back of proton pump inhibitorsAndrei Evgenyevich KarateevProton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumatic (above all nonsteroidal anti-inflammatory) drugs. PPIs are noteworthy for ease of use, efficacy, and excellent tolerability. Nevertheless, they are able to cause a number of serious class-specific adverse reactions. Some of these complications, such as osteoporosis progression and metabolic effect of methotrexate, may be of great importance for rheumatologic practice. This review is a critical analysis of the data available in the literature on the safety of PPIs and a risk-benefit assessment when they are usedhttps://rsp.mediar-press.net/rsp/article/view/1658helicobacter pyloriproton pump inhibitorsadverse reactionsenteric infectionspneumoniahelicobacter pyloriosteoporosismethotrexateclopidogrel
collection DOAJ
language Russian
format Article
sources DOAJ
author Andrei Evgenyevich Karateev
spellingShingle Andrei Evgenyevich Karateev
Six stabs in the back of proton pump inhibitors
Научно-практическая ревматология
helicobacter pylori
proton pump inhibitors
adverse reactions
enteric infections
pneumonia
helicobacter pylori
osteoporosis
methotrexate
clopidogrel
author_facet Andrei Evgenyevich Karateev
author_sort Andrei Evgenyevich Karateev
title Six stabs in the back of proton pump inhibitors
title_short Six stabs in the back of proton pump inhibitors
title_full Six stabs in the back of proton pump inhibitors
title_fullStr Six stabs in the back of proton pump inhibitors
title_full_unstemmed Six stabs in the back of proton pump inhibitors
title_sort six stabs in the back of proton pump inhibitors
publisher IMA-PRESS LLC
series Научно-практическая ревматология
issn 1995-4484
1995-4492
publishDate 2013-06-01
description Proton pump inhibitors (PPIs) are the most important class of drugs used for the therapy of acid-dependent diseases and states of the gastrointestinal tract (GIT). In rheumatologic practice, PPIs are an essential drug to treat and prevent upper GIT pathology occurring with the intake of antirheumatic (above all nonsteroidal anti-inflammatory) drugs. PPIs are noteworthy for ease of use, efficacy, and excellent tolerability. Nevertheless, they are able to cause a number of serious class-specific adverse reactions. Some of these complications, such as osteoporosis progression and metabolic effect of methotrexate, may be of great importance for rheumatologic practice. This review is a critical analysis of the data available in the literature on the safety of PPIs and a risk-benefit assessment when they are used
topic helicobacter pylori
proton pump inhibitors
adverse reactions
enteric infections
pneumonia
helicobacter pylori
osteoporosis
methotrexate
clopidogrel
url https://rsp.mediar-press.net/rsp/article/view/1658
work_keys_str_mv AT andreievgenyevichkarateev sixstabsinthebackofprotonpumpinhibitors
_version_ 1721235870919426048